Wilson K M, Fregly M J
J Appl Physiol (1985). 1985 Feb;58(2):534-43. doi: 10.1152/jappl.1985.58.2.534.
Systemic administration of angiotensin II (ANG II) (200 micrograms/kg sc) to the rat induced a hypothermic response that was characterized within 12 min by a reduction in the rate of O2 consumption, vasodilation of the tail, and a 1.3 degrees C fall in colonic temperature. Administration of ANG II in doses ranging from 10 to 200 micrograms/kg resulted in a decrease in colonic and an increase in tail skin temperature. Angiotensin I (ANG I) (200 micrograms/kg sc) induced a similar hypothermic response which was abolished by pretreatment with the ANG I-converting enzyme inhibitor, captopril (35 mg/kg ip). The interaction of ANG II with cholinergic and adrenergic pathways was evaluated to determine possible mechanisms. Treatment with ANG II (200 micrograms/kg sc) and propranolol, a beta-adrenoceptor antagonist (6 mg/kg ip), resulted in a greater depression of colonic temperature (Tco) than was observed with ANG II alone but did not affect the increase in tail skin temperature (Tsk) accompanying administration of ANG II. When ANG II was administered in combination with the beta-adrenergic agonist, isoproterenol (50 micrograms/kg ip), Tco remained at control levels, whereas an enhancement of the ANG II-induced increase in Tsk occurred. Administration of ANG II in combination with atropine sulfate (6 mg/kg ip), a muscarinic receptor antagonist which crosses the blood-brain barrier, significantly reduced the extent of the fall in Tco without affecting the increase in Tsk. The combined treatment of ANG II and the quaternary analogue, atropine methyl nitrate (3.25 mg/kg ip), which does not cross the blood-brain barrier, failed to affect the hypothermic responses to ANG II. These results suggest that the hypothermic responses to ANG II may be mediated through a central cholinergic pathway and possibly influenced by an adrenergic component. The inability of both adrenergic and cholinergic blockers to affect the vasodilatory response of the tail of the rat to administration of ANG II suggests that the mechanisms subserving heat production can be blocked independently of those subserving heat loss.
给大鼠皮下注射血管紧张素II(ANG II)(200微克/千克)可诱导体温降低反应,其特征为在12分钟内耗氧率降低、尾部血管舒张以及结肠温度下降1.3摄氏度。给予剂量范围为10至200微克/千克的ANG II会导致结肠温度降低,尾部皮肤温度升高。血管紧张素I(ANG I)(200微克/千克皮下注射)诱导了类似的体温降低反应,而用血管紧张素I转换酶抑制剂卡托普利(35毫克/千克腹腔注射)预处理可消除该反应。评估了ANG II与胆碱能和肾上腺素能途径的相互作用以确定可能的机制。用ANG II(200微克/千克皮下注射)和β-肾上腺素能受体拮抗剂普萘洛尔(6毫克/千克腹腔注射)进行治疗,导致结肠温度(Tco)的降低幅度比单独使用ANG II时更大,但不影响ANG II给药时伴随的尾部皮肤温度(Tsk)升高。当ANG II与β-肾上腺素能激动剂异丙肾上腺素(50微克/千克腹腔注射)联合给药时,Tco保持在对照水平,而ANG II诱导的Tsk升高增强。将ANG II与硫酸阿托品(6毫克/千克腹腔注射)联合给药,硫酸阿托品是一种可穿过血脑屏障的毒蕈碱受体拮抗剂,可显著降低Tco下降的程度,而不影响Tsk升高。ANG II与季铵类似物硝酸甲基阿托品(3.25毫克/千克腹腔注射)联合治疗,硝酸甲基阿托品不能穿过血脑屏障,未能影响对ANG II的体温降低反应。这些结果表明,对ANG II的体温降低反应可能通过中枢胆碱能途径介导,并可能受肾上腺素能成分影响。肾上腺素能和胆碱能阻滞剂均无法影响大鼠尾部对ANG II给药的血管舒张反应,这表明维持产热的机制可独立于维持散热的机制而被阻断。